Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Hvidovre University Hospital46 enrolled

Overview

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV Infections HIV-Associated Lipodystrophy Syndrome

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * over 18 years of age * Participated in and completed the HIGH: low study * informed consent signed Exclusion Criteria: * Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study

Locations (1)

Klinisk Forskningscenter, Hvidovre Hospital

Hvidovre, Hvidovre, Denmark

Outcomes

Primary Outcomes

Quality of life

Time frame: 6 months follow-up

Secondary Outcomes

Metabolism

Time frame: 6 months follow-up

Central Contacts

Katrine MH Andersen, stud.med.

CONTACT

45-36-322-108 katrine.harries.andersen@hvh.regionh.dk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.